Loading clinical trials...
Loading clinical trials...
Risk Stratifying COPD Exacerbations: a Prospective Study
To identify clinical characteristics on presentation which predict differential outcomes in patients with exacerbation of COPD.
Exacerbations of COPD (ECOPD) are heterogenous but are often considered as a single clinical entity. Clinical characteristics on presentation may predict outcome of patients with ECOPD. DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects. ROME classification was recently proposed to better risk stratify ECOPD according to symptoms, physiological parameters and laboratory findings on admission, but no prospective validation study is available so far. This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD.
Age
18 - 100 years
Sex
ALL
Healthy Volunteers
No
Charles Wong
Hong Kong, Other, Hong Kong
Pamela Youde Nethersole Eastern Hospital
Hong Kong, Hong Kong
Start Date
February 1, 2023
Primary Completion Date
February 1, 2024
Completion Date
February 1, 2025
Last Updated
December 27, 2023
500
ESTIMATED participants
Observation only
OTHER
Lead Sponsor
Pamela Youde Nethersole Eastern Hospital
NCT07351929
NCT05958563
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06347536